| Curcumin May Have Therapeutic Value In Treating Scleroderma |
|
|
|
| Tuesday, 27 October 2009 17:04 |
|
It has long been used in both Ayurvedic and Chinese medicine as an anti-inflammatory, to treat digestive and liver problems, skin diseases, and wounds. Preliminary human evidence, albeit poor quality, suggests possible efficacy in the management of dyspepsia or heartburn, hyperlipidemia or high cholesterol, and scabies, when used on the skin. Recent research shows that curcumin, a component of turmeric, may benefit people who suffer from Scleroderma. Curcumin is also a powerful antioxidant and antioxidants scavenge damaging particles in the body known as free radicals, which damage cell membranes, tamper with DNA, and even cause cell death. In addition, curcumin reduces inflammation by lowering levels of two inflammatory enzymes (called COX-2 and LOX) in the body and stops platelets from clumping together to form blood clots. They have concluded that, "curcumin may have therapeutic value in treating scleroderma". This is especially appealing as a treatment modality because curcumin is extremely non-toxic and is beneficial for a host of other disorders including many cancers, heart disease, and Alzheimer's disease. Turmeric is available in the following forms:
The use of herbs is a time-honored approach to strengthening the body and treating disease. Herbs, however, can trigger side effects and may interact with other herbs, supplements, or medications. For these reasons, herbs should be taken with care. Turmeric and curcumin are considered safe when taken at the recommended doses. However, taking large amounts of turmeric for long periods of time may produce stomach upset and, in extreme cases, ulcers. People who have gallstones or obstruction of the bile passages should talk to their doctor before taking turmeric. Although it is safe to eat foods containing turmeric, pregnant and breastfeeding women should not take turmeric supplements. For more information on turmeric and curcumin, you're welcome to visit the following resources: |
More articles :
» Role of ACE Inhibitors in Preventing Scleroderma Renal Crisis Remains Unclear
Scleroderma patients on angiotensin-converting enzyme inhibitors at the onset of Scleroderma renal crisis do not appear to have worse outcomes than do those not taking the antihypertensive agents prior to the acute renal function deterioration,...
» June Is Scleroderma Awareness Month!
The month of June is Scleroderma Awareness Month around the world, and would like to encourage each and everyone of you, to become advocates by raising awareness and educating others about this often progressive, autoimmune connective tissue disease...
» Bev Myers Starting Support Group In Shipley
A Shipley woman who has a rare auto-immune disease is hoping to set up a support group for fellow sufferers. is a largely unknown disease where the immune system attacks the body instead of protecting it. Bev Myers, a marketing consultant, was...
» Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP is a Potent Inhibitor of Pulmonary Fibrosis
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology...
» Actelion Pharmaceuticals Announces Commercial Availability Of Epoprostenol For Injection For The Treatment Of Pulmonary Arterial Hypertension
Actelion Pharmaceuticals US, Inc. today announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and...
» Shyanne Adams Heading To London Courtesy Of The Make-A-Wish Foundation
It wasn't until Shyanne Adams started feeling better recently that she realized just how hard the past year has been. “I think I was in shock the whole year,” said the 14-year-old Eagle Valley Middle School eighth-grader. “I was depressed. I...


